Capital Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AWA
Capital Financial Services's BMY Position: Q4 2022 in Review
Capital Financial Services reduced its Bristol-Myers Squibb (BMY) stake by 9.2% in Q4 2022, selling an estimated $78K and leaving 10,269 shares worth $739K. The position accounts for 1.02% of the portfolio, ranked #35.
Capital Financial Services first reported a position in BMY in Q4 2020 and has held it in 9 quarters since. The position peaked at $865K in Q2 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- Capital Financial Services held 10,269 shares of Bristol-Myers Squibb worth $739K as of Q4 2022.
- Capital Financial Services sold 1,035 Bristol-Myers Squibb shares in Q4 2022, an estimated $78K.
- Bristol-Myers Squibb made up 1.02% of Capital Financial Services's portfolio in Q4 2022, its #35 holding.
- Capital Financial Services first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 9 quarters since.
- Capital Financial Services's Bristol-Myers Squibb position peaked at $865K in Q2 2022.
- 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on Capital Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.